35 /100
MEDIUM RISK
Score updated Jul 14, 2026

MAIA — MAIA Biotechnology, Inc. Dilution Risk Tracker

Track MAIA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MAIA — Get alerts when the score changes →

As of July 14, 2026, MAIA Biotechnology, Inc. (MAIA) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. MAIA Biotechnology, Inc. has a market capitalization of $84.51M, 60.80M shares outstanding, 32 institutional holders tracked. Key dilution vectors include 452.7K outstanding warrants.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.33 approaching $1 threshold
🔔 Track MAIA — Get forecast alerts →

💹 Market Data

Market Cap$84.51M
Shares Outstanding60.80M
Float51.46M
CashN/A
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

32 institutional holders · 15.19M shares
#1 Solas Capital Management, LLC 4.30M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.15M shares
#3 Alyeska Investment Group, L.P. 2.50M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.41M
Days to Cover5.8
% of Float6.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MAIA Shareholders

MAIA Biotechnology, Inc. (MAIA) has a DilutionScore of 35/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 452,731 outstanding warrants for MAIA. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for MAIA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MAIA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track MAIA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MAIA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MAIA
📊 MAIA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MAIA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.